2018-2023 Global Ursodeoxycholic Acid Drug Product Consumption Market Report

Publisher Name :
Date: 10-Aug-2018
No. of pages: 165

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Ursodeoxycholic Acid Drug Product market for 2018-2023.

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.

The classification of Ursodeoxycholic Acid Drug Product includes Capsule and Tablet. And the proportion of Capsule in 2017 is about 94.8%, and the proportion is in decreasing trend from 2013 to 2018, In China, the major product is tablet, and with low concentration UDCA, and the price is also low than other manufacturers. The major products of Dr. Falk Pharma, Daewoong Pharmaceutical, Teva are capsule.

Ursodeoxycholic Acid Drug Product can be applied in Gallstone, Hepatopathy, Biliary Disease and Other. The most of Ursodeoxycholic Acid Drug Product is used in Gallstone, and the market share of that is about 36.5% in 2017.

North America is the largest sales place, with a sales market share nearly 30% in 2017. Following North America, Europe is the second largest sales place with the Sales market share of 22.1%. Ursodeoxycholic Acid Drug Product market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.

Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, etc. are the global leading manufactures in the world. In the future, more generic manufacturers will enter into this industry.

In North America, Epic Pharma is leading manufacturers, Teva, Lannett and Mylan are major suppliers of Ursodeoxycholic Acid Drug Product in USA market. In China, Dr. Falk Pharma is leading manufacturers, the market share is about 81% in 2017. In Japan, Mitsubishi Tanabe Pharma is leading manufacturers, the market share is about 52% in 2017. In Korea, Daewoong Pharmaceutical is leading manufacturers, the market share is about 86.1% in 2017

Over the next five years, LPI(LP Information) projects that Ursodeoxycholic Acid Drug Product will register a 11.9% CAGR in terms of revenue, reach US$ 1900 million by 2023, from US$ 970 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Ursodeoxycholic Acid Drug Product market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Capsule

- Tablet

Segmentation by application:

- Gallstone

- Hepatopathy

- Biliary Disease

- Other

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Dr. Falk Pharma

- Daewoong Pharmaceutical

- Teva

- Epic Pharma

- Mitsubishi Tanabe Pharma

- Lannett

- Mylan

- Bruschettini

- Impax

- Shanghai Pharma

- Grindeks

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Ursodeoxycholic Acid Drug Product consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Ursodeoxycholic Acid Drug Product market by identifying its various subsegments.

- Focuses on the key global Ursodeoxycholic Acid Drug Product manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Ursodeoxycholic Acid Drug Product with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Ursodeoxycholic Acid Drug Product submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Ursodeoxycholic Acid Drug Product Consumption Market Report

Table of Contents

2018-2023 Global Ursodeoxycholic Acid Drug Product Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ursodeoxycholic Acid Drug Product Consumption 2013-2023
2.1.2 Ursodeoxycholic Acid Drug Product Consumption CAGR by Region
2.2 Ursodeoxycholic Acid Drug Product Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Ursodeoxycholic Acid Drug Product Consumption by Type
2.3.1 Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
2.3.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Type (2013-2018)
2.3.3 Global Ursodeoxycholic Acid Drug Product Sale Price by Type (2013-2018)
2.4 Ursodeoxycholic Acid Drug Product Segment by Application
2.4.1 Gallstone
2.4.2 Hepatopathy
2.4.3 Biliary Disease
2.4.4 Other
2.5 Ursodeoxycholic Acid Drug Product Consumption by Application
2.5.1 Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
2.5.2 Global Ursodeoxycholic Acid Drug Product Value and Market Share by Application (2013-2018)
2.5.3 Global Ursodeoxycholic Acid Drug Product Sale Price by Application (2013-2018)

3 Global Ursodeoxycholic Acid Drug Product by Players
3.1 Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players
3.1.1 Global Ursodeoxycholic Acid Drug Product Sales by Players (2016-2018)
3.1.2 Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players (2016-2018)
3.2 Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players
3.2.1 Global Ursodeoxycholic Acid Drug Product Revenue by Players (2016-2018)
3.2.2 Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players (2016-2018)
3.3 Global Ursodeoxycholic Acid Drug Product Sale Price by Players
3.4 Global Ursodeoxycholic Acid Drug Product Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Ursodeoxycholic Acid Drug Product Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Ursodeoxycholic Acid Drug Product Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Ursodeoxycholic Acid Drug Product by Regions
4.1 Ursodeoxycholic Acid Drug Product by Regions
4.1.1 Global Ursodeoxycholic Acid Drug Product Consumption by Regions
4.1.2 Global Ursodeoxycholic Acid Drug Product Value by Regions
4.2 Americas Ursodeoxycholic Acid Drug Product Consumption Growth
4.3 APAC Ursodeoxycholic Acid Drug Product Consumption Growth
4.4 Europe Ursodeoxycholic Acid Drug Product Consumption Growth
4.5 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Growth

5 Americas
5.1 Americas Ursodeoxycholic Acid Drug Product Consumption by Countries
5.1.1 Americas Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018)
5.1.2 Americas Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018)
5.2 Americas Ursodeoxycholic Acid Drug Product Consumption by Type
5.3 Americas Ursodeoxycholic Acid Drug Product Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Ursodeoxycholic Acid Drug Product Consumption by Countries
6.1.1 APAC Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018)
6.1.2 APAC Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018)
6.2 APAC Ursodeoxycholic Acid Drug Product Consumption by Type
6.3 APAC Ursodeoxycholic Acid Drug Product Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Ursodeoxycholic Acid Drug Product by Countries
7.1.1 Europe Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018)
7.1.2 Europe Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018)
7.2 Europe Ursodeoxycholic Acid Drug Product Consumption by Type
7.3 Europe Ursodeoxycholic Acid Drug Product Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Ursodeoxycholic Acid Drug Product by Countries
8.1.1 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018)
8.2 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Type
8.3 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Ursodeoxycholic Acid Drug Product Distributors
10.3 Ursodeoxycholic Acid Drug Product Customer

11 Global Ursodeoxycholic Acid Drug Product Market Forecast
11.1 Global Ursodeoxycholic Acid Drug Product Consumption Forecast (2018-2023)
11.2 Global Ursodeoxycholic Acid Drug Product Forecast by Regions
11.2.1 Global Ursodeoxycholic Acid Drug Product Forecast by Regions (2018-2023)
11.2.2 Global Ursodeoxycholic Acid Drug Product Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Ursodeoxycholic Acid Drug Product Forecast by Type
11.8 Global Ursodeoxycholic Acid Drug Product Forecast by Application

12 Key Players Analysis
12.1 Dr. Falk Pharma
12.1.1 Company Details
12.1.2 Ursodeoxycholic Acid Drug Product Product Offered
12.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Dr. Falk Pharma News
12.2 Daewoong Pharmaceutical
12.2.1 Company Details
12.2.2 Ursodeoxycholic Acid Drug Product Product Offered
12.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Daewoong Pharmaceutical News
12.3 Teva
12.3.1 Company Details
12.3.2 Ursodeoxycholic Acid Drug Product Product Offered
12.3.3 Teva Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Teva News
12.4 Epic Pharma
12.4.1 Company Details
12.4.2 Ursodeoxycholic Acid Drug Product Product Offered
12.4.3 Epic Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Epic Pharma News
12.5 Mitsubishi Tanabe Pharma
12.5.1 Company Details
12.5.2 Ursodeoxycholic Acid Drug Product Product Offered
12.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Mitsubishi Tanabe Pharma News
12.6 Lannett
12.6.1 Company Details
12.6.2 Ursodeoxycholic Acid Drug Product Product Offered
12.6.3 Lannett Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Lannett News
12.7 Mylan
12.7.1 Company Details
12.7.2 Ursodeoxycholic Acid Drug Product Product Offered
12.7.3 Mylan Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Mylan News
12.8 Bruschettini
12.8.1 Company Details
12.8.2 Ursodeoxycholic Acid Drug Product Product Offered
12.8.3 Bruschettini Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Bruschettini News
12.9 Impax
12.9.1 Company Details
12.9.2 Ursodeoxycholic Acid Drug Product Product Offered
12.9.3 Impax Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Impax News
12.10 Shanghai Pharma
12.10.1 Company Details
12.10.2 Ursodeoxycholic Acid Drug Product Product Offered
12.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Shanghai Pharma News
12.11 Grindeks

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Ursodeoxycholic Acid Drug Product
Table Product Specifications of Ursodeoxycholic Acid Drug Product
Figure Ursodeoxycholic Acid Drug Product Report Years Considered
Figure Market Research Methodology
Figure Global Ursodeoxycholic Acid Drug Product Consumption Growth Rate 2013-2023 (MT)
Figure Global Ursodeoxycholic Acid Drug Product Value Growth Rate 2013-2023 ($ Millions)
Table Ursodeoxycholic Acid Drug Product Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Capsule
Table Major Players of Capsule
Figure Product Picture of Tablet
Table Major Players of Tablet
Table Global Consumption Sales by Type (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
Figure Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Revenue by Type (2013-2018) ($ million)
Table Global Ursodeoxycholic Acid Drug Product Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Ursodeoxycholic Acid Drug Product Value Market Share by Type (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Sale Price by Type (2013-2018)
Figure Ursodeoxycholic Acid Drug Product Consumed in Gallstone
Figure Global Ursodeoxycholic Acid Drug Product Market: Gallstone (2013-2018) (MT)
Figure Global Ursodeoxycholic Acid Drug Product Market: Gallstone (2013-2018) ($ Millions)
Figure Global Gallstone YoY Growth ($ Millions)
Figure Ursodeoxycholic Acid Drug Product Consumed in Hepatopathy
Figure Global Ursodeoxycholic Acid Drug Product Market: Hepatopathy (2013-2018) (MT)
Figure Global Ursodeoxycholic Acid Drug Product Market: Hepatopathy (2013-2018) ($ Millions)
Figure Global Hepatopathy YoY Growth ($ Millions)
Figure Ursodeoxycholic Acid Drug Product Consumed in Biliary Disease
Figure Global Ursodeoxycholic Acid Drug Product Market: Biliary Disease (2013-2018) (MT)
Figure Global Ursodeoxycholic Acid Drug Product Market: Biliary Disease (2013-2018) ($ Millions)
Figure Global Biliary Disease YoY Growth ($ Millions)
Figure Ursodeoxycholic Acid Drug Product Consumed in Other
Figure Global Ursodeoxycholic Acid Drug Product Market: Other (2013-2018) (MT)
Figure Global Ursodeoxycholic Acid Drug Product Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
Figure Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Value by Application (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Value Market Share by Application (2013-2018)
Figure Global Ursodeoxycholic Acid Drug Product Value Market Share by Application (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Sale Price by Application (2013-2018)
Table Global Ursodeoxycholic Acid Drug Product Sales by Players (2016-2018) (MT)
Table Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players (2016-2018)
Figure Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players in 2016
Figure Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players in 2017
Table Global Ursodeoxycholic Acid Drug Product Revenue by Players (2016-2018) ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players (2016-2018)
Figure Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players in 2016
Figure Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players in 2017
Table Global Ursodeoxycholic Acid Drug Product Sale Price by Players (2016-2018)
Figure Global Ursodeoxycholic Acid Drug Product Sale Price by Players in 2017
Table Global Ursodeoxycholic Acid Drug Product Manufacturing Base Distribution and Sales Area by Players
Table Players Ursodeoxycholic Acid Drug Product Products Offered
Table Ursodeoxycholic Acid Drug Product Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Ursodeoxycholic Acid Drug Product Consumption by Regions 2013-2018 (MT)
Table Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Regions 2013-2018
Figure Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Regions 2013-2018
Table Global Ursodeoxycholic Acid Drug Product Value by Regions 2013-2018 ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Value Market Share by Regions 2013-2018
Figure Global Ursodeoxycholic Acid Drug Product Value Market Share by Regions 2013-2018
Figure Americas Ursodeoxycholic Acid Drug Product Consumption 2013-2018 (MT)
Figure Americas Ursodeoxycholic Acid Drug Product Value 2013-2018 ($ Millions)
Figure APAC Ursodeoxycholic Acid Drug Product Consumption 2013-2018 (MT)
Figure APAC Ursodeoxycholic Acid Drug Product Value 2013-2018 ($ Millions)
Figure Europe Ursodeoxycholic Acid Drug Product Consumption 2013-2018 (MT)
Figure Europe Ursodeoxycholic Acid Drug Product Value 2013-2018 ($ Millions)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption 2013-2018 (MT)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Value 2013-2018 ($ Millions)
Table Americas Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018) (MT)
Table Americas Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries (2013-2018)
Figure Americas Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries in 2017
Table Americas Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018) ($ Millions)
Table Americas Ursodeoxycholic Acid Drug Product Value Market Share by Countries (2013-2018)
Figure Americas Ursodeoxycholic Acid Drug Product Value Market Share by Countries in 2017
Table Americas Ursodeoxycholic Acid Drug Product Consumption by Type (2013-2018) (MT)
Table Americas Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
Figure Americas Ursodeoxycholic Acid Drug Product Consumption Market Share by Type in 2017
Table Americas Ursodeoxycholic Acid Drug Product Consumption by Application (2013-2018) (MT)
Table Americas Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
Figure Americas Ursodeoxycholic Acid Drug Product Consumption Market Share by Application in 2017
Figure United States Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure United States Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Canada Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Canada Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Mexico Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Mexico Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Table APAC Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018) (MT)
Table APAC Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries (2013-2018)
Figure APAC Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries in 2017
Table APAC Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018) ($ Millions)
Table APAC Ursodeoxycholic Acid Drug Product Value Market Share by Countries (2013-2018)
Figure APAC Ursodeoxycholic Acid Drug Product Value Market Share by Countries in 2017
Table APAC Ursodeoxycholic Acid Drug Product Consumption by Type (2013-2018) (MT)
Table APAC Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
Figure APAC Ursodeoxycholic Acid Drug Product Consumption Market Share by Type in 2017
Table APAC Ursodeoxycholic Acid Drug Product Consumption by Application (2013-2018) (MT)
Table APAC Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
Figure APAC Ursodeoxycholic Acid Drug Product Consumption Market Share by Application in 2017
Figure China Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure China Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Japan Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Japan Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Korea Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Korea Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Southeast Asia Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure India Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure India Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Australia Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Australia Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Table Europe Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018) (MT)
Table Europe Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries (2013-2018)
Figure Europe Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries in 2017
Table Europe Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018) ($ Millions)
Table Europe Ursodeoxycholic Acid Drug Product Value Market Share by Countries (2013-2018)
Figure Europe Ursodeoxycholic Acid Drug Product Value Market Share by Countries in 2017
Table Europe Ursodeoxycholic Acid Drug Product Consumption by Type (2013-2018) (MT)
Table Europe Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
Figure Europe Ursodeoxycholic Acid Drug Product Consumption Market Share by Type in 2017
Table Europe Ursodeoxycholic Acid Drug Product Consumption by Application (2013-2018) (MT)
Table Europe Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
Figure Europe Ursodeoxycholic Acid Drug Product Consumption Market Share by Application in 2017
Figure Germany Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Germany Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure France Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure France Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure UK Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure UK Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Italy Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Italy Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Russia Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Russia Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Spain Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Spain Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Countries (2013-2018) (MT)
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Market Share by Countries in 2017
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Value Market Share by Countries in 2017
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Type (2013-2018) (MT)
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Market Share by Type in 2017
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Application (2013-2018) (MT)
Table Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Market Share by Application in 2017
Figure Egypt Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Egypt Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure South Africa Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure South Africa Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Israel Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Israel Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure Turkey Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure Turkey Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Ursodeoxycholic Acid Drug Product Consumption Growth 2013-2018 (MT)
Figure GCC Countries Ursodeoxycholic Acid Drug Product Value Growth 2013-2018 ($ Millions)
Table Ursodeoxycholic Acid Drug Product Distributors List
Table Ursodeoxycholic Acid Drug Product Customer List
Figure Global Ursodeoxycholic Acid Drug Product Consumption Growth Rate Forecast (2018-2023) (MT)
Figure Global Ursodeoxycholic Acid Drug Product Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Consumption Forecast by Countries (2018-2023) (MT)
Table Global Ursodeoxycholic Acid Drug Product Consumption Market Forecast by Regions
Table Global Ursodeoxycholic Acid Drug Product Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Value Market Share Forecast by Regions
Figure Americas Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Americas Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure APAC Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure APAC Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Europe Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Europe Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Middle East & Africa Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure United States Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure United States Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Canada Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Canada Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Mexico Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Mexico Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Brazil Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Brazil Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure China Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure China Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Japan Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Japan Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Korea Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Korea Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Southeast Asia Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Southeast Asia Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure India Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure India Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Australia Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Australia Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Germany Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Germany Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure France Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure France Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure UK Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure UK Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Italy Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Italy Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Russia Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Russia Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Spain Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Spain Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Egypt Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Egypt Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure South Africa Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure South Africa Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Israel Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Israel Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure Turkey Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure Turkey Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Figure GCC Countries Ursodeoxycholic Acid Drug Product Consumption 2018-2023 (MT)
Figure GCC Countries Ursodeoxycholic Acid Drug Product Value 2018-2023 ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Consumption Forecast by Type (2018-2023) (MT)
Table Global Ursodeoxycholic Acid Drug Product Consumption Market Share Forecast by Type (2018-2023)
Table Global Ursodeoxycholic Acid Drug Product Value Forecast by Type (2018-2023) ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Value Market Share Forecast by Type (2018-2023)
Table Global Ursodeoxycholic Acid Drug Product Consumption Forecast by Application (2018-2023) (MT)
Table Global Ursodeoxycholic Acid Drug Product Consumption Market Share Forecast by Application (2018-2023)
Table Global Ursodeoxycholic Acid Drug Product Value Forecast by Application (2018-2023) ($ Millions)
Table Global Ursodeoxycholic Acid Drug Product Value Market Share Forecast by Application (2018-2023)
Table Dr. Falk Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Epic Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Epic Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Epic Pharma Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Lannett Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lannett Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lannett Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Ursodeoxycholic Acid Drug Product Market Share (2016-2018)
Table Bruschettini Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bruschettini Ursodeoxycholic A
  • Global Anti-infective Ophthalmic Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 122
    Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals. Scope of the Report: This report focuses on the Anti-infective Ophthal......
  • Global Cannabis Oil Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 124
    Cannabis oil is from the marijuana plant (cannabis indicas). The oil is extracted from the leaves of the cannabis plant. It contains high levels of THC. It is used for medicinal purposes and as a recreational drug. Cannabis oil reached considerable popularity when a man in Canada named Rick Simpson began distributing this concentrate, albeit illegally, as a medicine. Rick's oil (commonly known as "Rick Simpson oil") brought the long studied knowledge about the anti-tumor and various medi......
  • Global Darbepoetin Alfa Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 124
    Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and ......
  • Global Hemostasis and Tissue Sealing Agents Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 136
    Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operati......
  • Global Humira Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 121
    Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa. Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis. ......
  • Global Hypromellose Acetate Succinate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 119
    Hypromellose acetate succinate is an enteric coating material which was first approved in Japan in 1987. As of January 2004, this product has been approved in Korea, several countries in Europe, and USA as well as in Japan. Scope of the Report: This report focuses on the Hypromellose Acetate Succinate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manuf......
  • Global IGY Polyclonal Antibodies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 120
    Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them. IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation proces......
  • Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Aug-2018        Price: US 3480 Onwards        Pages: 122
    Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development. Scope of the Report: This report focuses on the Platinum based Cancer Drug......
  • Global Hepatocyte Growth Factor Market Professional Survey Report 2018
    Published: 20-Aug-2018        Price: US 3500 Onwards        Pages: 104
    This report studies the global Hepatocyte Growth Factor market status and forecast, categorizes the global Hepatocyte Growth Factor market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs